CDLX Investors Have Opportunity to Lead Cardlytics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, Feb. 6, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cardlytics, Inc. (“Cardlytics” or “the Company”) (NASDAQ: CDLX) for violations of §§10(b) and 20(a) of the Securities Exchange…